BASELINE COMPARISON: None ADDITIONAL COMPARISON(S): None TECHNIQUE/PROTOCOL: Adult brain tumor protocol without...

TL;DR: Your MRI shows some new areas of enhancement (brightening) in your brain that could be tumor growth or could be swelling from your immunotherapy treatment—your doctor needs to determine which one it is.

KEY POINTS:

• The radiologist found increased enhancement (brightening on the MRI) along the edges of your surgery cavity and some new small enhancing spots nearby
• The report uses the term "indeterminate," which means the imaging findings could represent either tumor progression OR treatment-related changes (swelling/inflammation from immunotherapy)
• Your BT-RADS score of 3b indicates "imaging worsening indeterminate for tumor and/or treatment effect"—this is a specific classification that tells your doctor the findings need clinical correlation
• This is a common challenge in brain tumor imaging: distinguishing between actual tumor regrowth and the body's inflammatory response to treatment
• ASL perfusion imaging (a specialized MRI technique that measures blood flow) was not performed, which could have provided additional information to help clarify the findings
• NEXT STEP: Schedule an urgent discussion with your neuro-oncology team to review these results and determine the next steps, which may include repeat imaging, biopsy, or treatment adjustments.

---

FULL ANSWER

Understanding Your MRI Report

Your recent brain MRI from [date removed], shows changes compared to your previous scan from [date removed]. Let me walk you through what the radiologist found and what it means.

What the Radiologist Saw

The resection cavity: You had surgery on your left frontal lobe (the front part of your brain on the left side), which created a cavity where the tumor was removed. This is normal and expected after brain surgery.

New enhancement: The radiologist noticed:

• Increased nodular enhancement (brightening) along the back edges of your surgery cavity, measuring approximately 1.7 x 2.2 cm
• New satellite lesions (small separate spots of enhancement) in the left superior frontal gyrus (the upper front part of your brain near the surgery site)—one measuring less than 1 cm and another very small punctate (dot-like) lesion
• Increased surrounding T2/FLAIR signal (a type of MRI signal that shows swelling/fluid in the brain tissue)

The Critical Uncertainty: "Indeterminate"

Here's the key challenge your radiologist is facing: The findings could mean two different things:

Possibility 1: Tumor Progression The new enhancement and satellite lesions could represent tumor cells regrowing or spreading near the surgery site.

Possibility 2: Treatment Effect (Pseudoprogression) According to the Musella Foundation's Brain Tumor Guide, approximately 20-30% of brain tumor patients show imaging findings that look like progression after radiation therapy and chemotherapy, but these actually represent treatment-related swelling and inflammation rather than true tumor growth. This phenomenon is called "pseudoprogression" or treatment effect.

Since you're currently on immunotherapy, your immune system is actively fighting the tumor, which can cause inflammation and swelling that mimics tumor progression on imaging.

What "BT-RADS Score 3b" Means

The radiologist assigned your scan a BT-RADS (Brain Tumor Reporting and Data System) score of 3b: "Imaging worsening indeterminate for tumor and/or treatment effect."

This score tells your oncology team that:

• The imaging has changed compared to your prior scan (worsening)
• The change could represent either tumor or treatment effects
• Clinical correlation with your symptoms, blood work, and overall clinical picture is needed to make the final determination

What Wasn't Done (and Why It Matters)

The report notes that ASL perfusion imaging was not performed. ASL (arterial spin labeling) is a specialized MRI technique that measures blood flow in the brain. According to NCCN Guidelines for brain tumor imaging, perfusion imaging can help distinguish between tumor progression (which typically shows increased blood flow) and treatment-related changes (which typically show decreased blood flow). This additional information could have helped clarify whether these findings represent true progression.

What This Means for Your Care

According to NCCN Guidelines for brain tumor management, when imaging findings are indeterminate like yours, your neuro-oncology team typically considers:

1. Clinical correlation: How are you feeling? Do you have new neurologic symptoms?
2. Repeat imaging: A follow-up MRI in 4-8 weeks to see if the findings are stable, growing, or resolving
3. Advanced imaging: Perfusion MRI, MR spectroscopy, or PET imaging to provide additional information
4. Tissue sampling: In some cases, a biopsy may be considered to definitively determine if the enhancement represents tumor or treatment effect
5. Treatment adjustments: Your oncologist may modify your immunotherapy or consider additional interventions based on the clinical picture

Important Context

The fact that you're on immunotherapy is actually relevant to interpreting these findings. Immunotherapy works by activating your immune system to attack cancer cells, and this immune activation can cause inflammation and swelling in the brain that appears as enhancement on MRI—even when the tumor is responding well to treatment.

Questions to Ask Your Neuro-Oncology Team

1. Do these findings represent tumor progression or treatment-related changes in your clinical judgment?
2. Would additional imaging studies (perfusion MRI, MR spectroscopy, or PET) help clarify these findings?
3. What is your recommendation for the next imaging interval—should we repeat the MRI sooner than planned?
4. Are there any changes you'd recommend to my current immunotherapy based on these findings?
5. If the findings remain indeterminate, would you consider a biopsy to definitively determine what's happening?
6. What symptoms should I watch for that would warrant urgent evaluation?

Bottom Line

Your MRI shows changes that require your neuro-oncology team's clinical judgment to interpret correctly. The radiologist appropriately flagged this as indeterminate because distinguishing between tumor progression and treatment-related changes is genuinely challenging in brain tumor imaging, especially during active immunotherapy. Your oncologist, who knows your complete clinical picture, symptoms, and treatment response, is the right person to determine what these findings mean for your care.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.